###begin article-title 0
Epidemiology of Doublet/Multiplet Mutations in Lung Cancers: Evidence that a Subset Arises by Chronocoordinate Events
###end article-title 0
###begin p 1
Conceived and designed the experiments: SS ZC. Performed the experiments: ZC. Analyzed the data: SS ZC CHB. Contributed reagents/materials/analysis tools: SS. Wrote the paper: SS ZC JF CHB. Helped with revised paper: JF.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 494 498 494 498 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGFR</italic>
###xml 503 507 503 507 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TP53</italic>
###xml 534 538 534 538 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGFR</italic>
###xml 631 635 631 635 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TP53</italic>
###xml 72 77 <span type="species:ncbi:10090">mouse</span>
###xml 367 372 <span type="species:ncbi:9606">human</span>
Evidence strongly suggests that spontaneous doublet mutations in normal mouse tissues generally arise from chronocoordinate events. These chronocoordinate mutations sometimes reflect "mutation showers", which are multiple chronocoordinate mutations spanning many kilobases. However, little is known about mutagenesis of doublet and multiplet mutations (domuplets) in human cancer. Lung cancer accounts for about 25% of all cancer deaths. Herein, we analyze the epidemiology of domuplets in the EGFR and TP53 genes in lung cancer. The EGFR gene is an oncogene in which doublets are generally driver plus driver mutations, while the TP53 gene is a tumor suppressor gene with a more typical situation in which doublets derive from a driver and passenger mutation.
###end p 3
###begin title 4
Methodology/Principal Findings
###end title 4
###begin p 5
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGFR</italic>
###xml 96 100 96 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGFR</italic>
###xml 123 127 123 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TP53</italic>
###xml 182 186 182 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGFR</italic>
###xml 191 195 191 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TP53</italic>
###xml 318 322 318 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGFR</italic>
###xml 327 331 327 331 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TP53</italic>
###xml 341 346 <span type="species:ncbi:9606">human</span>
###xml 451 456 <span type="species:ncbi:10090">mouse</span>
EGFR mutations identified by sequencing were collected from 66 published papers and our updated EGFR mutation database (). TP53 mutations were collected from IARC version 12 (). For EGFR and TP53 doublets, no clearly significant differences in race, ethnicity, gender and smoking status were observed. Doublets in the EGFR and TP53 genes in human lung cancer are elevated about eight- and three-fold, respectively, relative to spontaneous doublets in mouse (6% and 2.3% versus 0.7%).
###end p 5
###begin title 6
Conclusions/Significance
###end title 6
###begin p 7
###xml 194 198 194 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGFR</italic>
###xml 276 280 276 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGFR</italic>
###xml 469 473 467 471 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TP53</italic>
###xml 262 270 <span type="species:ncbi:9606">patients</span>
Although no one characteristic is definitive, the aggregate properties of doublet and multiplet mutations in lung cancer are consistent with a subset derived from chronocoordinate events in the EGFR gene: i) the eight frameshift doublets (present in 0.5% of all patients with EGFR mutations) are clustered and produce a net in-frame change; ii) about 32% of doublets are very closely spaced (</=30 nt); and iii) multiplets contain two or more closely spaced mutations. TP53 mutations in lung cancer are very closely spaced (</=30 nt) in 33% of doublets, and multiplets generally contain two or more very closely spaced mutations. Work in model systems is necessary to confirm the significance of chronocoordinate events in lung and other cancers.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 204 207 204 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003714-Hanahan1">[1]</xref>
###xml 209 212 209 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003714-Knudson1">[2]</xref>
###xml 375 378 363 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003714-Sjoblom1">[3]</xref>
###xml 755 758 731 734 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003714-Bielas1">[4]</xref>
###xml 759 762 735 738 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003714-Loeb2">[6]</xref>
###xml 812 815 788 791 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003714-Tomlinson1">[7]</xref>
###xml 817 820 793 796 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003714-Tomlinson2">[8]</xref>
###xml 1220 1223 1196 1199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003714-Wang1">[9]</xref>
Cancer is a heterogeneous, multi-step, complex genetic disease resulting from accumulated mutations. Cancers generally were considered to arise by the accumulation of an estimated 5-7 causative mutations [1], [2]. Recently, however, Vogelstein and others have shown in breast and colorectal cancers that individual tumors accumulate approximately90 somatically mutated genes [3]. However, a much smaller number (estimated to be approximately11) are likely to be involved in tumorigenesis in any given tumor. The accumulation of so many contributory mutations is hard to explain solely by the frequency of multiple independent mutation events. The accumulation of mutations in certain cancers may reflect a mutator phenotype with globally random mutations [4]-[6]. Sequential selection offers another explanation [7], [8]. One mutation causes over-replication, giving rise to a clone, which further over-replicates due to a second mutation, etc. Recently the existence of mutation showers were reported, raising the possibility of "cancer in an instant" if scattered mutation showers occur. Mutation showers were found after analyses of intragenic doublet mutations revealed that they were clustered and chronocoordinate [9].
###end p 9
###begin p 10
###xml 53 57 53 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGFR</italic>
###xml 298 302 298 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003714-Chen1">[10]</xref>
###xml 364 368 364 368 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGFR</italic>
###xml 498 502 498 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003714-Kobayashi1">[11]</xref>
###xml 504 508 504 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003714-Pao1">[12]</xref>
###xml 528 532 528 532 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TP53</italic>
###xml 537 541 537 541 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lacI</italic>
###xml 627 632 <span type="species:ncbi:10090">mouse</span>
We demonstrated that the majority of doublets in the EGFR gene have a different mutation pattern relative to singlets and consist of driver plus driver mutations, due to sequential or chronocoordinate mutations, putatively followed by functional selection of two individually sub-optimal mutations [10]. In addition, acquired second mutations (e.g. T790M) in four EGFR doublets have been reported after treatment with gefitinib and erlotinib and associated with drug resistance and disease relapse [11], [12]. In contrast, most TP53 and lacI doublets show driver plus passenger mutations in lung cancers and in normal Big Blue mouse tissue, respectively. However, the epidemiology and mechanisms underlying mutagenesis of doublets and multiple mutations are unclear.
###end p 10
###begin p 11
###xml 93 97 93 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGFR</italic>
###xml 209 213 209 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TP53</italic>
###xml 341 345 341 345 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGFR</italic>
###xml 350 354 350 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TP53</italic>
###xml 524 545 524 545 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
###xml 550 554 550 554 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGFR</italic>
###xml 793 797 793 797 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGFR</italic>
###xml 802 806 802 806 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TP53</italic>
###xml 410 415 <span type="species:ncbi:9606">human</span>
###xml 443 448 <span type="species:ncbi:10090">mouse</span>
###xml 848 853 <span type="species:ncbi:9606">human</span>
To elucidate the frequency of doublets and the distinct mutation pattern and spectrum in the EGFR gene, the epidemiology of doublet mutations in lung cancer is analyzed and compared to that of doublets in the TP53 gene. Herein, we find that smoking status, race, ethnicity, gender, and age are not risk factors for doublet occurrence in the EGFR and TP53 genes. The relative frequency of doublets is higher in human lung cancer than in normal mouse tissue. The existence of OMIDI pairs (see Terminology and Abbreviations in Materials and Methods) in EGFR, the high frequency of allelic versus compound heterozygote doublets, the high frequency of closely spaced doublets, and the clustering in multiplets are consistent with chronocoordinate mutations contributing to at least a subset of the EGFR and TP53 doublet and multiplet mutations found in human lung cancer.
###end p 11
###begin title 12
Results
###end title 12
###begin title 13
Epidemiology of doublet mutations in the EGFR and TP53 genes in lung cancer
###end title 13
###begin p 14
###xml 119 123 119 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGFR</italic>
###xml 130 137 130 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003714-t001">Table 1</xref>
###xml 139 147 139 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003714.s003">Table S1</xref>
###xml 229 231 227 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs</italic>
###xml 169 177 <span type="species:ncbi:9606">patients</span>
Analysis by smoking status, gender, and ethnicity does not reveal a significant difference in doublet frequency in the EGFR gene (Table 1, Table S1). The average age of patients with singlets and doublets is similar (61.4+/-11.3 vs 65.8+/-10.3).
###end p 14
###begin title 15
###xml 20 24 20 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGFR</italic>
###xml 29 33 29 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TP53</italic>
###xml 58 59 58 59 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table-fn" rid="nt101">1</xref>
The epidemiology of EGFR and TP53 doublets versus singlets1 in lung cancer.
###end title 15
###begin p 16
###xml 27 31 27 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGFR</italic>
###xml 43 47 43 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TP53</italic>
Total number of mutations: EGFR, n = 1627; TP53, n = 2387.
###end p 16
###begin p 17
###xml 51 55 51 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGFR</italic>
The number of singlets, doublets and multiplets in EGFR is 1526, 98 and 5, respectively
###end p 17
###begin p 18
###xml 51 55 51 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TP53</italic>
The number of singlets, doublets and multiplets in TP53 is 2326, 54 and 7, respectively
###end p 18
###begin p 19
The number and percentage of doublets among the total singlets+doublets in each category by row.
###end p 19
###begin p 20
NA: not available.
###end p 20
###begin p 21
###xml 20 24 20 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TP53</italic>
###xml 94 98 94 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TP53</italic>
###xml 167 169 167 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs</italic>
###xml 187 194 187 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003714-t001">Table 1</xref>
###xml 196 204 196 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003714.s004">Table S2</xref>
###xml 318 322 318 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGFR</italic>
###xml 327 331 327 331 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TP53</italic>
The results for the TP53 gene in lung cancer are similar with one exception. The frequency of TP53 doublets is significantly higher in Asians than in Caucasians (3.2% vs 1.8%, P = 0.03) (Table 1, Table S2), but this is not significant when corrected for multiple comparison (six Fisher's Exact Tests performed for the EGFR and TP53 genes). Additional data are necessary to evaluate this point.
###end p 21
###begin p 22
###xml 165 169 165 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lacI</italic>
###xml 227 234 227 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003714-t002">Table 2</xref>
###xml 82 87 <span type="species:ncbi:9606">human</span>
###xml 187 191 <span type="species:ncbi:10090">mice</span>
Overall, 98/1627 (6.0%) of EGFR mutations and 54/2387 (2.3%) of TP53 mutations in human lung cancers are doublets, a much higher frequency than that observed in the lacI gene in Big Blue mice (8-fold and 3-fold, respectively) (Table 2).
###end p 22
###begin title 23
###xml 46 50 46 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGFR</italic>
###xml 66 70 66 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LacI</italic>
###xml 86 90 86 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TP53</italic>
A comparison of doublet characteristics among EGFR (lung cancer), LacI (Big Blue) and TP53 (lung cancer).
###end title 23
###begin p 24
An OMIDI pair can result in a net in-frame mutation if the second OMIDI restores the reading frame and no nonsense codon occurs between the first OMIDI and the second OMIDI.
###end p 24
###begin title 25
Doublets tend to cluster in the EGFR and TP53 genes in lung cancer: the "half-life of mutation spacing" is 9 bp and 15 bp, respectively
###end title 25
###begin p 26
###xml 12 16 12 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lacI</italic>
###xml 202 206 202 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003714-Hill1">[13]</xref>
###xml 208 212 208 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003714-Buettner1">[14]</xref>
###xml 266 270 266 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGFR</italic>
###xml 436 444 432 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003714.s003">Table S1</xref>
###xml 460 464 456 460 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lacI</italic>
###xml 501 505 497 501 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGFR</italic>
###xml 587 588 583 584 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 641 650 637 646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003714.s001">Figure S1</xref>
###xml 769 790 765 786 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
Spontaneous lacI doublets (0.7% of total mutations) are clustered with a spacing fitting an exponential distribution and show a similar mutation pattern to singlets, indicating a chronocoordinate event [13], [14]. Based on the doublet spacing between two mutations, EGFR doublets can be divided into two groups: the proximal group (<100 bp, average spacing 22.8+/-24.4-bp) and the distal group (>809 bp, average spacing 12.3+/-5.1 kb) (Table S1). Analogous to lacI doublets, a subset [40% (39/98)] of EGFR doublets occurring in the same exon with proximal spacing shows an exponential (R2 = 0.9979) rather than a quasi-uniform distribution (Figure S1). Half the doublets have mutations separated by 9 bp or less (the "half-life of mutation spacing"; see Terminology in Materials and Methods).
###end p 26
###begin p 27
###xml 29 33 29 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TP53</italic>
###xml 201 202 199 200 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 213 221 211 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003714.s004">Table S2</xref>
###xml 223 232 221 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003714.s001">Figure S1</xref>
###xml 458 462 454 458 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TP53</italic>
###xml 595 604 591 600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003714.s006">Tables S4</xref>
###xml 609 611 605 607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003714.s007">S5</xref>
The spacing distribution for TP53 doublets in lung cancer occurring in the same exon (43%, 23/54) also shows proximal spacing (<86 bp, average 20.2+/-20.9 bp) and fits to an exponential distribution (R2 = 0.979) (Table S2, Figure S1) with a half-life of mutation spacing of 15 bp. Doublets occurring in different exons have distal spacing (131-4504 bp, average 1317.9+/-1000 bp) separated by an intron. A similar spacing to that in lung cancer was found for TP53 doublets within the same exon in breast and colorectal cancers, with a half-life of mutation spacing of 24 and 16 bp, respectively (Tables S4 and S5).
###end p 27
###begin p 28
###xml 25 29 25 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGFR</italic>
###xml 34 38 34 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TP53</italic>
###xml 290 294 288 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lacI</italic>
###xml 305 310 <span type="species:ncbi:10090">mouse</span>
Thus, about one-third of EGFR and TP53 doublets are highly clustered (</= 30 bp) and all doublets occurring within a single exon have an inter-mutation spacing that is exponentially distributed rather than the expected quasi-uniform distribution, consistent with chronocoordinate events in lacI in normal mouse tissue.
###end p 28
###begin title 29
The OMIDI pairs are strong evidence for clustered chronocoordinate mutations
###end title 29
###begin p 30
###xml 84 87 84 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FIX</italic>
###xml 145 149 145 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003714-Halangoda1">[15]</xref>
###xml 150 154 150 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003714-Roberts1">[18]</xref>
###xml 266 270 266 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGFR</italic>
###xml 389 393 389 393 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGFR</italic>
###xml 477 498 477 498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
###xml 550 557 550 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003714-t003">Table 3</xref>
###xml 559 568 559 568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003714.s002">Figure S2</xref>
###xml 912 916 912 916 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGFR</italic>
###xml 1194 1198 1194 1198 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGFR</italic>
###xml 1584 1591 1584 1591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003714-t002">Table 2</xref>
###xml 1593 1601 1593 1601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003714.s003">Table S1</xref>
###xml 34 39 <span type="species:ncbi:9606">human</span>
###xml 60 65 <span type="species:ncbi:10090">mouse</span>
The great majority of spontaneous human germlime or somatic mouse MIDIs are OMIDIs (FIX, Big Blue); indeed, about half are single base deletions [15]-[18]. In contrast, there is a very low fraction of OMIDIs (0.26%, 4/1526) and nonsense mutations (0.13%, 2/1526) in EGFR singlets, consistent with a strong selection for mutations that alter, rather than delete, function. Eight of 98 (6%) EGFR doublets contain a pair of frameshift mutations (OMIDI pairs; see abbreviations in Materials and Methods). All eight of the OMIDI pairs are closely spaced (Table 3, Figure S2), with the net result being an in-frame mutation. Given one OMIDI mutation, a second random mutation 3' to the first (either IMIDI or OMIDI) will restore reading frame only 1/3 of the time, and a sub-fraction of that third is still protein truncating because a nonsense mutation occurs prior to the second mutation. In total 0.49% of reported EGFR mutations (8/1627) are clustered OMIDI pairs with no truncation mutation occurring before the second OMIDI. These eight OMIDI pairs are expected to reside on the same allele; otherwise, compound heterozygous OMIDI doublets will lead to two allelic truncations, eliminating all EGFR gene function. Meanwhile, both of the clustered OMIDIs should also occur in rapid succession (chronocoordinate mutations) within the same cell cycle because the frequency of secondary mutations randomly occurring in a proliferation-deficient cell resulting from a single OMIDI is rare. The remaining 14 deletions (in exons), 9 indels and 3 doublets are all in-frame (IMIDI) mutations (Table 2; Table S1).
###end p 30
###begin title 31
###xml 58 62 58 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGFR</italic>
The characteristics of eight OMIDI paired doublets in the EGFR gene in lung cancer.
###end title 31
###begin p 32
Drug Response: PR-partial response; SD-stable disease; PD-progressive disease.
###end p 32
###begin p 33
NA: Not Available.
###end p 33
###begin p 34
###xml 55 59 55 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TP53</italic>
###xml 104 112 104 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003714.s004">Table S2</xref>
###xml 162 166 162 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGFR</italic>
The mutations in the single OMIDI pair reported in the TP53 gene are 2309 bp apart, in different exons (Table S2, ID # 14373), and, unlike the OMIDI pairs in the EGFR gene, do not together restore the reading frame.
###end p 34
###begin title 35
EGFR multiplets are consistent with a singlet and a highly clustered chronocoordinate second mutation
###end title 35
###begin p 36
###xml 36 40 36 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGFR</italic>
###xml 172 179 172 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003714-t004">Table 4</xref>
###xml 368 372 368 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lacI</italic>
###xml 383 388 <span type="species:ncbi:10090">mouse</span>
Four triplets and one quadruplet in EGFR were found at a frequency of 0.3% (5/1627) of lung cancers with mutations prior to treatment with tyrosine kinase inhibitor (TKI) (Table 4). It is of interest that pairs of mutations in each of the triplets and three mutations within the quadruplet are tightly clustered with proximal spacing (3-60 bp), similar to doublets in lacI in normal mouse tissues. The third mutation is located in a different exon with distal spacing. The data are consistent with sequential selection of two mutations in which one of the mutations is a chronocoordinate doublet or triplet.
###end p 36
###begin p 37
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TP53</italic>
###xml 99 107 99 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003714.s005">Table S3</xref>
###xml 527 536 525 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003714.s008">Tables S6</xref>
###xml 538 540 536 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003714.s009">S7</xref>
TP53 multiplets (6 triplets and one quadruplet) also account for 0.3% (7/2387) of total mutations (Table S3). Five multiplets (71%, 5/7) reside in the same exon or two exons, consistent with one mutation and one chronocoordinate doublet. Seven multiplets had mutations separated by 15 spacing regions. Of these, six were highly clustered (</=30 nt) and nine were within 100 nucleotides or less. Eighty percent (16/20) of multiple mutations in breast cancer and 76% (25/33) in colorectal cancer also reside in one or two exons (Tables S6, S7).
###end p 37
###begin title 38
###xml 66 70 66 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGFR</italic>
The mutation characteristics and spacing within multiplets in the EGFR gene.
###end title 38
###begin p 39
Spacing (bp) between mutations 1 and 2, followed by the spacing between mutations 2 and 3, etc.
###end p 39
###begin p 40
Drug Response: PR-partial response; SD-stable disease; PD-progressive disease.
###end p 40
###begin p 41
The deletion is presumed to be the most common 15 bp deletion (c2235_2249).
###end p 41
###begin p 42
###xml 68 76 <span type="species:ncbi:9606">patients</span>
The identical set of four mutations was reported in three different patients.
###end p 42
###begin p 43
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bold Face</bold>
Bold Face indicates that one mutation in the multiplet resides in a different exon relative to the other clustered mutations in the same exon.
###end p 43
###begin p 44
###xml 86 90 86 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGFR</italic>
###xml 95 99 95 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TP53</italic>
###xml 118 125 118 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003714-t005">Table 5</xref>
###xml 163 167 163 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGFR</italic>
###xml 218 222 218 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TP53</italic>
###xml 259 263 259 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TP53</italic>
A comparison of OMIDI pairs and closely spaced doublet and multiplet mutations in the EGFR and TP53 genes is shown in Table 5. The frequency of OMIDI pairs in the EGFR gene is approximately 10-fold greater than in the TP53 gene (and the one OMIDI pair in the TP53 gene does not result in a net in-frame mutation), reflecting the more frequent selection of mutations that alter, rather than delete, EGFR protein function. The frequency of closely spaced mutations in doublets and multiplets in both genes is similar.
###end p 44
###begin title 45
###xml 55 59 55 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGFR</italic>
###xml 64 68 64 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TP53</italic>
Closely spaced doublets and multiplets detected in the EGFR and TP53 genes.
###end title 45
###begin p 46
###xml 27 31 27 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGFR</italic>
###xml 43 47 43 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TP53</italic>
Total number of mutations: EGFR, n = 1627; TP53, n = 2387.
###end p 46
###begin title 47
All characterized EGFR doublets are allelic: a significant subset of chronocoordinate mutations provides an alternative explanation
###end title 47
###begin p 48
###xml 78 82 78 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGFR</italic>
###xml 115 119 115 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003714-Chen1">[10]</xref>
###xml 256 260 256 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGFR</italic>
###xml 363 371 363 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003714.s003">Table S1</xref>
###xml 373 377 373 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003714-Chen1">[10]</xref>
###xml 379 383 379 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003714-Yokoyama1">[19]</xref>
###xml 385 389 385 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003714-Tam1">[20]</xref>
###xml 913 917 913 917 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003714-Chen1">[10]</xref>
At face value, the allelism data suggests that the driver/driver mutations in EGFR need to be on the same molecule [10]. However, the existence of a substantial subset of chronocoordinate mutations provides an alternative explanation. Sixteen heterozygous EGFR doublets from three different studies have been analyzed by cloning or allele-specific amplification (Table S1) [10], [19], [20]. Subsequent sequencing of the products revealed that all these alleles were either doubly mutated or wild type, indicating that, in every case, both mutations were located on the same allele. If the doublet pairs result from independent events, half may be expected to be compound heterozygotes. The observation of 100% allelism (16/16) vs. zero compound heterozygotes (p = 0.002) may reflect that, functionally, the driver/driver mutations are required to be on the same molecule even though the EGFR protein forms dimers [10]. However, the data are also consistent with 50% chronocoordinate events, putatively during strand replication or patch repair, and 50% independent sequential mutations without a requirement that both mutations be on the same molecule (8 of 8 allelic mutations observed when 4 of 8 are expected at random; p</=0.08).
###end p 48
###begin p 49
###xml 89 93 89 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TP53</italic>
Unfortunately, to our knowledge, allelic analysis has not been performed on heterozygous TP53 doublets.
###end p 49
###begin title 50
Discussion
###end title 50
###begin p 51
###xml 388 392 388 392 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGFR</italic>
###xml 397 401 397 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TP53</italic>
###xml 478 483 <span type="species:ncbi:9606">human</span>
We present the first analysis of the epidemiology of doublets in lung cancer. Smoking status, race, ethnicity, gender, and age are not risk factors for doublet occurrence in lung cancer. The high frequency of clustered doublets, the exponential distribution of spacing, the occurrence of in-frame clustered OMIDI pairs, the allelic nature of doublets, and the clustering of multiplets in EGFR and TP53 are consistent with a significant minority of chronocoordinate mutations in human cancer. However there are caveats for each of the above observations (see below).
###end p 51
###begin p 52
###xml 54 58 54 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGFR</italic>
###xml 63 67 63 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TP53</italic>
###xml 285 289 285 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TP53</italic>
###xml 572 576 572 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003714-Sommer2">[21]</xref>
###xml 578 582 578 582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003714-Hill2">[22]</xref>
###xml 77 82 <span type="species:ncbi:9606">human</span>
###xml 138 143 <span type="species:ncbi:10090">mouse</span>
We demonstrate that doublets are more frequent in the EGFR and TP53 genes in human cancer than in spontaneous somatic mutations in normal mouse tissue. Within the constraints of sample size, doublet frequency does not obviously depend on smoking status, gender, ethnicity, or age. The TP53 gene is mutated in about half of all tumors and can be used as a "mutagen test," that is, the relative frequencies of the different types of mutation can be used as an epidemiological tool to explore the contribution of exogenous mutagens vs. endogenous processes in breast cancers [21], [22]. We hypothesized that the higher mutation rates expected in smokers would more often produce doublet mutations. However, there is no significant difference between smokers and non-smokers, consistent with doublets and multiplets arising from endogenous processes.
###end p 52
###begin title 53
Data are consistent with chronocoordinate mutations (with caveats)
###end title 53
###begin p 54
###xml 60 64 60 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGFR</italic>
###xml 69 73 69 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TP53</italic>
###xml 250 254 250 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TP53</italic>
###xml 272 276 272 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGFR</italic>
###xml 456 558 454 556 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">The main value of the present analysis is to generate data that constrain our hypotheses and, by Occam</italic>
###xml 559 667 557 665 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">s razor, generate a simple hypothesis (the subset of chronocoordinate events) consistent with multiple data.</italic>
Several aspects of the data are consistent with a subset of EGFR and TP53 doublets arising from choronocoordinate events rather than from hypermutability (random distributed spacing) or sequential selection. About 32-35% of the doublets found in the TP53 (35%, 19/54) and EGFR (32%, 31/98) genes are either OMIDI pairs or highly clustered doublets separated by </=30 nt. However, there are caveats for each inference that must be ruled out in future work. The main value of the present analysis is to generate data that constrain our hypotheses and, by Occam's razor, generate a simple hypothesis (the subset of chronocoordinate events) consistent with multiple data.
###end p 54
###begin p 55
###xml 147 151 147 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGFR</italic>
###xml 293 297 293 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGFR</italic>
(1) The OMIDI pairs are the best evidence for chronocoordinate mutations. For most genes, the majority of spontaneous MIDIs are OMIDIs, but in the EGFR gene, OMIDIs are rare, consistent with the overall selection for altered function rather than lack of function. It is notable that the eight EGFR doublets containing OMIDI pairs all have closely spaced mutations that result in a net in-frame mutation, thus producing an EGFR protein with potentially altered, rather than absent, function. However, no experimental evidence of a protein containing one of these doublet mutations has been demonstrated. The most reasonable explanation for this occurrence is through chronocoordinate mutations that are selected together for altered protein function. An alternative explanation is that OMIDI pairs might somehow be sequential, although random mutations within a few nucleotides in the genome must be extremely unlikely.
###end p 55
###begin p 56
###xml 72 76 72 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGFR</italic>
###xml 202 206 202 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGFR</italic>
###xml 211 215 211 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TP53</italic>
###xml 245 246 245 246 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
(2) The relatively high frequency of clustered doublet mutations in the EGFR gene is consistent with chronocoordinate mutations. The exponential distribution of the spacing between the two mutations in EGFR and TP53 doublets in the same exons (R2 = >0.98) is highly unlikely by chance.
###end p 56
###begin p 57
###xml 54 58 54 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TP53</italic>
###xml 119 123 119 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TP53</italic>
###xml 272 276 272 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TP53</italic>
###xml 318 322 318 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003714-Hill1">[13]</xref>
A simulation was performed previously for each of the TP53 exons 5-9 to test the null hypothesis that the mutations in TP53 doublets are independent events and that the distribution of the spacing between the two mutations depends only on the spectrum of mutations in the TP53 gene and the size of the mutation target [13]. The first mutation of each simulated doublet was drawn randomly based on the observed distribution of singlet mutations in a given exon. Using the singlet distribution from the TP53 IARC database (release 8) accounts for bias that may result from closely spaced hot spots. The second mutation in the doublet was drawn randomly based on a uniform distribution over the TP53 coding sequence for that exon, since it is likely to be a "hitchhiker" (passenger) mutation, rather than a driver mutation for the tumor.
###end p 57
###begin p 58
###xml 76 80 76 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TP53</italic>
###xml 201 204 201 204 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">not</underline>
###xml 554 558 554 558 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TP53</italic>
###xml 548 553 <span type="species:ncbi:9606">human</span>
The mutation spacing in the simulated doublets was compared with 402 actual TP53 doublets in the IARC database from all types of cancer. The results demonstrated that two mutations within doublets are not independent events by statistical comparison of the observed and expected distributions, and indicated that more doublets occurred with a mutation spacing of less than 30 nucleotides than expected by chance (P = 0.03, 0.02, 0.0006, and 0.01 for exons 5-8). These results are consistent with the occurrence of chronocoordinate mutations in the human TP53 gene. An alternate explanation for the clustering of doublets is that they may represent some as yet unappreciated functional constraints.
###end p 58
###begin p 59
(3) The allelic nature of doublets is consistent with chronocoordinate mutations. Among 98 doublet pairs reported in the literature, only a few have been analyzed to determine whether they are present on the same or different alleles. Among 16 doublet pairs tested by cloning or allele-specific amplification, all 16 pairs were found to be present on the same allele. However, for the remaining doublet pairs, in which cloning or allele-specific amplification was not performed, the possibility that the mutations were present on different alleles cannot be ruled out.
###end p 59
###begin p 60
(4) The relatively high frequency of multiplets with two or more clustered mutations and an additional mutation at a distal location also argues for a chronocoordinate mutational event plus an independent single mutational event. Again, an alternative explanation could involve functional constraints on the clustered mutations.
###end p 60
###begin p 61
###xml 365 369 365 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003714-Drake1">[23]</xref>
###xml 371 375 371 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003714-Drake2">[24]</xref>
###xml 103 108 <span type="species:ncbi:9606">human</span>
###xml 320 325 <span type="species:ncbi:4932">yeast</span>
In aggregate, these data are consistent with a contribution of clustered chronocoordinate mutations to human cancer. An excess of doublets or multiplets with a subset of clustered distribution occurs more frequently than predicted by chance in a wide range of organisms, including riboviruses, DNA viruses, prokaryotes, yeast, and eukaryotic cell lines and tissues [23], [24].
###end p 61
###begin title 62
Data support driver plus passenger TP53 doublets in lung cancer
###end title 62
###begin p 63
###xml 138 142 138 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003714-Sommer3">[25]</xref>
###xml 151 155 151 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TP53</italic>
###xml 367 371 367 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003714-Strauss1">[26]</xref>
###xml 373 377 373 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003714-Strauss2">[27]</xref>
###xml 424 428 424 428 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TP53</italic>
###xml 497 501 497 501 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TP53</italic>
###xml 629 633 629 633 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGFR</italic>
###xml 643 647 643 647 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003714-Chen1">[10]</xref>
About 22% of the second mutations in doublets are expected to be silent if they are "passenger" mutations, rather than "driver" mutations [25]. In the TP53 doublets, there are five silent and two intronic nucleotide changes (13%, 7/54), not significantly different from the 23.5% silent nucleotide changes expected to occur with random passenger mutations (p = 0.46) [26], [27]. Silent nucleotide changes (18%, 4/22) within TP53 multiplets are also close to 23.5%. Together, these data imply that TP53 doublets and multiplets consist of a driver plus passenger mutation pattern, in contrast to the driver/driver pattern found in EGFR doublets [10].
###end p 63
###begin p 64
###xml 64 67 64 67 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003714-Wang1">[9]</xref>
###xml 58 63 <span type="species:ncbi:10090">mouse</span>
###xml 431 436 <span type="species:ncbi:9606">human</span>
Doublet mutations are associated with mutation showers in mouse [9]. The advent of massively parallel sequencing can facilitate the analysis of sufficient numbers of samples to define any doublets and then determine whether these doublets are associated with mutation showers in cancer. The non-random clustering mutations in mutation showers should provide more definitive data for the occurrence of chronocoordinate mutations in human cancers. The contribution of mutation showers to cancer remains to be determined.
###end p 64
###begin title 65
Materials and Methods
###end title 65
###begin title 66
Terminology and abbreviations
###end title 66
###begin title 67
Mutation spectrum
###end title 67
###begin p 68
The relative frequencies of mutations at specific sites.
###end p 68
###begin title 69
Mutation pattern
###end title 69
###begin p 70
The relative frequencies of different types of mutations, e.g., C to T transitions vs. T to C transitions.
###end p 70
###begin title 71
Singlet
###end title 71
###begin p 72
###xml 43 47 43 47 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003714-Hill1">[13]</xref>
A single mutation identified within a gene [13].
###end p 72
###begin title 73
Tandem-base mutation (TBM)
###end title 73
###begin p 74
###xml 64 68 64 68 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003714-Hill3">[28]</xref>
###xml 70 74 70 74 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003714-Buettner2">[29]</xref>
A mutation that results in base changes at adjacent nucleotides [28], [29].
###end p 74
###begin title 75
Doublet
###end title 75
###begin p 76
Two mutations identified within a gene including a mix of TBM and non-TBM mutations.
###end p 76
###begin title 77
Multiplet
###end title 77
###begin p 78
Three or more mutations identified within a gene, excluding the situation in which all mutations are adjacent. Multiplets can include a mix of TBM and non-TBM mutations.
###end p 78
###begin title 79
Domuplets
###end title 79
###begin p 80
###xml 70 74 70 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lacI</italic>
###xml 104 107 104 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003714-Wang1">[9]</xref>
A mutant that is either a doublet or a multiplet. Approximately 1% of lacI mutant plaques are domuplets [9].
###end p 80
###begin title 81
MIDI
###end title 81
###begin p 82
###xml 122 126 122 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003714-Chen1">[10]</xref>
Microinsertion, deletion, or indel; an insertion, deletion or indel that results in a gain or loss of 1 to 50 nucleotides [10].
###end p 82
###begin title 83
IMIDI
###end title 83
###begin p 84
In-frame MIDI
###end p 84
###begin title 85
OMIDI
###end title 85
###begin p 86
Out-of-frame MIDI
###end p 86
###begin title 87
Half-life of mutation spacing
###end title 87
###begin p 88
From the exponential fit to the data, the interval of mutation spacing corresponding to the interval encompassing half of the remaining mutations within the sample. This is analogous to the half-life of a radioisotope.
###end p 88
###begin title 89
Chronocoordinate mutation
###end title 89
###begin p 90
###xml 117 121 117 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003714-Hill1">[13]</xref>
Multiple mutations occurring within the same cell cycle and in rapid succession, typically within seconds to minutes [13].
###end p 90
###begin title 91
Mutation shower
###end title 91
###begin p 92
###xml 65 68 65 68 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003714-Wang1">[9]</xref>
Chronocoordinate multiple mutations that span multiple kilobases [9].
###end p 92
###begin title 93
Silent mutation
###end title 93
###begin p 94
###xml 311 315 311 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003714-Ketterling1">[30]</xref>
A neutral mutation that does not change protein structure, including synonymous coding region changes. It is recognized that occasional mutation types overlap, e.g., a silent mutation may activate a cryptic splice site or may inactivate the normal splice site if it disrupts the splice donor consensus sequence [30]. In practice very few such overlaps were found.
###end p 94
###begin title 95
Samples and mutational analysis
###end title 95
###begin p 96
###xml 86 90 86 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGFR</italic>
###xml 182 186 182 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGFR</italic>
###xml 205 209 205 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003714-Chen1">[10]</xref>
###xml 211 215 211 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003714-Gu1">[31]</xref>
###xml 220 224 220 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TP53</italic>
###xml 680 684 664 668 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TP53</italic>
###xml 341 349 <span type="species:ncbi:9606">patients</span>
In order to investigate the mechanism and characteristics of doublets and multiplets, EGFR mutations identified by sequencing were collected from 66 published papers and our updated EGFR mutation database [10], [31] (). TP53 mutations were collected from IARC version 12 () and excluded mutations in pulmonary fibrosis and in lung cancer in patients exposed to smoky coal emissions, radon, mustard gas, asbestos, heavy metals, and atomic bomb radiation (gamma-rays). We also excluded two papers in which multiple mutations comprised >50% of the total mutations, most likely due to PCR artifacts, since multiple mutations generally make up only approximately3% of total mutations. TP53 mutations in breast and colorectal cancers also were retrieved and the spacing distribution of doublets/multiplets was analyzed.
###end p 96
###begin title 97
Statistical Analysis
###end title 97
###begin p 98
Mutation patterns and other categorical count distributions were tested for significant differences by the Fisher's Exact Test or unordered RxC contingency tables using the "Fisher-Freeman-Halton" test implemented by the StatXact statistical analysis software package (CYTEL Software Corporation, Cambridge, MA).
###end p 98
###begin title 99
Supporting Information
###end title 99
###begin p 100
A subset of doublets shows proximal spacing and fits to exponential distribution in the EGFR and p53 genes in lung cancer. Panel A shows the separation (in base pairs) between the two mutations in EGFR proximal doublets (n = 37). The separation distances were divided into three groups, with spacings of 1-41 bp, 42-82 bp, and 83-123 bp, and plotted at the midpoint of each group (20, 60, and 100, respectively). Separation is defined here as the number of nucleotides between, but not including, the two mutations in a doublet. For MIDIs, separation is defined as the number of nucleotides between, but not including, the start of the first and second MIDIs. Panel B shows the spacing (in base pairs) between the two mutations in p53 proximal doublets (n = 23). The separation distances were divided into three groups, with spacings of 1-31 bp, 32-62 bp, and 63-93 bp, and plotted at the midpoint of each group (15, 30, and 45, respectively).
###end p 100
###begin p 101
(0.62 MB PPT)
###end p 101
###begin p 102
Click here for additional data file.
###end p 102
###begin p 103
Doublets in the EGFR gene that form OMIDI pairs The wild type (wt) EGFR sequence in exon 19 from nucleotides 2227 to 2280 is shown. The eight OMIDI pairs in lung cancer are diagrammed to show the deletions (in magenta), insertions (in green) and a region that is duplicated (in yellow). Note that two of the doublets consist of two deletions each, five doublets consist of one deletion plus an indel, and one doublet has a duplication (insertion) plus an indel. In each case, the reading frame is restored (see net deletion).
###end p 103
###begin p 104
(0.03 MB DOC)
###end p 104
###begin p 105
Click here for additional data file.
###end p 105
###begin p 106
Supplementary Table 1
###end p 106
###begin p 107
(0.07 MB XLS)
###end p 107
###begin p 108
Click here for additional data file.
###end p 108
###begin p 109
Supplementary Table 2
###end p 109
###begin p 110
(0.07 MB XLS)
###end p 110
###begin p 111
Click here for additional data file.
###end p 111
###begin p 112
Supplemenatary Table 3
###end p 112
###begin p 113
(0.03 MB XLS)
###end p 113
###begin p 114
Click here for additional data file.
###end p 114
###begin p 115
Supplementary Table 4
###end p 115
###begin p 116
(0.08 MB XLS)
###end p 116
###begin p 117
Click here for additional data file.
###end p 117
###begin p 118
Supplementary Table 5
###end p 118
###begin p 119
(0.11 MB XLS)
###end p 119
###begin p 120
Click here for additional data file.
###end p 120
###begin p 121
Supplementary Table 6
###end p 121
###begin p 122
(0.04 MB XLS)
###end p 122
###begin p 123
Click here for additional data file.
###end p 123
###begin p 124
Supplementary Table 7
###end p 124
###begin p 125
(0.06 MB XLS)
###end p 125
###begin p 126
Click here for additional data file.
###end p 126
###begin p 127
We thank Wenyan Li and Jiesheng Chen for DNA sequencing.
###end p 127
###begin title 128
References
###end title 128
###begin article-title 129
The hallmarks of cancer.
###end article-title 129
###begin article-title 130
Two genetic hits (more or less) to cancer.
###end article-title 130
###begin article-title 131
###xml 34 39 <span type="species:ncbi:9606">human</span>
The consensus coding sequences of human breast and colorectal cancers.
###end article-title 131
###begin article-title 132
Mutator phenotype in cancer: timing and perspectives.
###end article-title 132
###begin article-title 133
A mutator phenotype in cancer.
###end article-title 133
###begin article-title 134
Multiple mutations and cancer.
###end article-title 134
###begin article-title 135
The mutation rate and cancer.
###end article-title 135
###begin article-title 136
###xml 81 84 <span type="species:ncbi:9615">dog</span>
Selection, the mutation rate and cancer: ensuring that the tail does not wag the dog.
###end article-title 136
###begin article-title 137
Evidence for mutation showers.
###end article-title 137
###begin article-title 138
EGFR somatic doublets in lung cancer are frequent and generally arise from a pair of driver mutations uncommonly seen as singlet mutations: one-third of doublets occur at five pairs of amino acids.
###end article-title 138
###begin article-title 139
EGFR mutation and resistance of non-small-cell lung cancer to gefitinib.
###end article-title 139
###begin article-title 140
Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain.
###end article-title 140
###begin article-title 141
Spontaneous multiple mutations show both proximal spacing consistent with chronocoordinate events and alterations with p53-deficiency.
###end article-title 141
###begin article-title 142
###xml 54 69 <span type="species:ncbi:10090">transgenic mice</span>
Evidence that proximal multiple mutations in Big Blue transgenic mice are dependent events.
###end article-title 142
###begin article-title 143
###xml 63 68 <span type="species:ncbi:10090">mouse</span>
Spontaneous microdeletions and microinsertions in a transgenic mouse mutation detection system: analysis of age, tissue, and sequence specificity.
###end article-title 143
###begin article-title 144
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human germline mutation in the factor IX gene.
###end article-title 144
###begin article-title 145
Searching for the 1 in 2,400,000: a review of dystrophin gene point mutations.
###end article-title 145
###begin article-title 146
EGFR point mutation in non-small cell lung cancer is occasionally accompanied by a second mutation or amplification.
###end article-title 146
###begin article-title 147
###xml 99 107 <span type="species:ncbi:9606">patients</span>
###xml 123 130 <span type="species:ncbi:4097">tobacco</span>
Distinct epidermal growth factor receptor and KRAS mutation patterns in non-small cell lung cancer patients with different tobacco exposure and clinicopathologic features.
###end article-title 147
###begin article-title 148
Mutagen test.
###end article-title 148
###begin article-title 149
p53 as a mutagen test in breast cancer.
###end article-title 149
###begin article-title 150
Clusters of mutations from transient hypermutability.
###end article-title 150
###begin article-title 151
Too many mutants with multiple mutations.
###end article-title 151
###begin article-title 152
The size distributions of proteins, mRNA, and nascent transcripts.
###end article-title 152
###begin article-title 153
Silent and multiple mutations in p53 and the question of the hypermutability of tumors.
###end article-title 153
###begin article-title 154
Role in tumorigenesis of silent mutations in the TP53 gene.
###end article-title 154
###begin article-title 155
Spontaneous tandem-base mutations (TBM) show dramatic tissue, age, pattern and spectrum specificity.
###end article-title 155
###begin article-title 156
###xml 32 37 <span type="species:ncbi:10090">mouse</span>
Tandem-based mutations occur in mouse liver and adipose tissue preferentially as G:C to T:A transversions and accumulate with age.
###end article-title 156
###begin article-title 157
Reported in vivo splice-site mutations in the factor IX gene: severity of splicing defects and a hypothesis for predicting deleterious splice donor mutations.
###end article-title 157
###begin article-title 158
Database of somatic mutations in EGFR with analyses revealing indel hotspots but no smoking-associated signature.
###end article-title 158
###begin p 159
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 159
###begin p 160
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: Institution.
###end p 160

